Varamir
Desk
News
Calendar
Pricing
Saved
Search
tickers or companies
⌘K
Start free
· no card
Sign in
RVMD compared with TNGX: revenue, margins and what each company keeps, and the suppliers and customers both name
RVMD
Revolution Medicines, Inc.
Change
Mkt cap
Revenue
Revenue
TNGX
Tango Therapeutics, Inc.
Change
Mkt cap
Revenue
Revenue
vs
Compare
RVMD
Revolution Medicines, Inc.
vs
TNGX
Tango Therapeutics, Inc.
Price
Mkt cap
Revenue
Revenue
Change
Change
Revenue flow
Supply chain
Price
Co-movers
Event sensitivity
Earnings history
Save comparison
Copy link
Revenue flow
Desk
News
Calendar
Saved
Search
RVMD
Revolution Medicines, Inc.
Change
199.24
· pre 212.54
· delayed
Mkt cap
$43.2B
Revenue
$198M
Q3 FY26
Revenue
—
TNGX
Tango Therapeutics, Inc.
Change
23.17
· pre 23.51
· delayed
Pre-market
Nov 5 '26
delayed
Mkt cap
$3.9B
Revenue
$54M
Q3 FY25
Revenue
$42M
FY24
vs
Compare
Pre-market
Nov 5 '26
delayed
RVMD
Revolution Medicines, Inc.
vs
TNGX
Tango Therapeutics, Inc.
199.24
pre 212.54
delayed
Price
23.17
pre 23.51
delayed
$43.2B
Mkt cap
$3.9B
Q3 FY26
$198M
Revenue
$54M
Q3 FY25
—
Revenue
$42M
FY24
Change
Change
RVMD
199.24
vs
TNGX
23.17
Pre-market
Nov 5 '26
delayed
Revenue flow
Supply chain
Price
Co-movers
Event sensitivity
Earnings history
Price
Supply-chain overlap
Revenue flow
RVMD: latest quarter is a loss; flow not drawable.
Method
›
Price
rebased to 0%
1D
1W
1M
3M
YTD
1Y
5Y
1D
1W
1M
3M
YTD
1Y
5Y
RVMD, solid
TNGX, dashed
Supply-chain overlap
direct ties · both sides
Sources
›
direct ties · both sides
Only RVMD
6
SNY
Sanofi
customer
RPRX
Royalty Pharma Investments 2019 ICAV (Royalty Pharma)
customer
—
Aethon Therapeutics
unlisted
supplier
—
Continental Stock Transfer & Trust
unlisted
supplier
2 more · RVMD chain
›
Shared
0
No shared counterparties.
Only TNGX
1
—
WuXi AppTec
unlisted
supplier
Role chip = supplier or customer
—
= no ticker (unlisted)
Source: SEC EDGAR